It is a pharma private limited company based in Noida, Uttar Pradesh, India, established in 2019.
2019 | Noida, Uttar Pradesh, India | ActiveUrsceal Pharma Private Limited, a active private limited company, was established on 24 May 2019 in Noida, Uttar Pradesh, India. Engaging in pharma contract r&d within the support service to organizations sector, it holds CIN: U85110UP2019PTC117309. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Pratap Dinesh Singh (Director), Shipra Srivastava (Director), Mohit Srivastava (Director). Past directors included Piush Khare. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No 7 Cabin No 2 4Th Floor Tower Ii, Plot No -C 25 Stellar It Park Sector 62, Noida, Uttar Pradesh, 201301.
U85110UP2019PTC117309
117309
24 May 2019
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Ursceal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pratap Dinesh Singh | Director | 29 Nov 2023 | Current |
| Shipra Srivastava | Director | 24 May 2019 | Current |
| Mohit Srivastava | Director | 25 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Apr 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ursceal Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.68% decrease. The company also saw a substantial fall in profitability, with a 87.92% decrease in profit. The company's net worth Soared by an impressive increase of 15.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ursceal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ursceal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ursceal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ursceal Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mohit Srivastava was appointed as a Director was appointed as a Director on 25 Apr 2025 & has been associated with this company since 7 months 8 days . was recorded as a recent event.
The activity Ursceal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Ursceal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The activity Pratap Dinesh Singh was appointed as a Director was appointed as a Director on 29 Nov 2023 & has been associated with this company since 2 years 3 days . was completed.
Progress on Shipra Srivastava was appointed as a Director was appointed as a Director on 24 May 2019 & has been associated with this company since 6 years 6 months . was documented.
Ursceal Pharma Private Limited was registered on 24 May 2019 with Roc Kanpur & aged 6 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Ursceal Pharma Private Limited is U85110UP2019PTC117309.
Ursceal Pharma Private Limited is headquartered at Office No 7 Cabin No 2 4Th Floor Tower Ii, Plot No -C 25 Stellar It Park Sector 62, Noida, Uttar Pradesh, 201301.
Ursceal Pharma Private Limited was incorporated on 24 May 2019.
The current directors of Ursceal Pharma Private Limited are
The primary industry of Ursceal Pharma Private Limited is Support Service To Organizations.
Ursceal Pharma Private Limited is unlisted.
The authorized capital of Ursceal Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Ursceal Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX